74147
碘海醇
analytical standard
别名:
5-[N-(2,3-二羟丙基)乙酰氨基]-2,4,6-三碘-N,N′-双(2,3-二羟丙基)异邻苯二甲酰亚胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C19H26I3N3O9
化学文摘社编号:
分子量:
821.14
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
266-164-2
Beilstein/REAXYS Number:
2406632
MDL number:
产品名称
碘海醇, analytical standard
InChI key
NTHXOOBQLCIOLC-UHFFFAOYSA-N
InChI
1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)
SMILES string
IC1=C(C(NCC(O)CO)=O)C(I)=C(C(NCC(CO)O)=O)C(I)=C1N(CC(CO)O)C(C)=O
grade
analytical standard
assay
≥95.0% (HPLC)
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
impurities
≤6.0% water
application(s)
clinical testing
format
neat
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
有关合适仪器技术的更多信息，请参考产品分析证书。如需进一步支持，请联系技术服务。
碘海醇可用作内标，用于通过 HPLC-UV 法测定人血浆、血清和尿液样品中的碘海醇。在肾衰竭研究中，它也可以用作模型化合物，通过碘海醇的血浆清除率分析碘海醇对肾小球滤过率（GFR）测量适用性。
General description
碘海醇是一种非离子型水溶性造影剂，用作测定肾功能水平的肾小球滤过率（GFR）的参考标记。它可以应用于血管造影和泌尿造影过程。
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Human pharmacokinetics of iohexol. A new nonionic contrast medium.
BO, et al.
Investigative Radiology, 18(2), 177-182 (1983)
Development and validation of an HPLC-UV method for determination of iohexol in human plasma.
Soman R S, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 816(1-2), 339-343 (2005)
Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment.
Cavalier E, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 396(1-2), 80-85 (2008)
Iohexol clearance for GFR-determination in renal failure?single or multiple plasma sampling?.
Sterner G, et al.
Nephrology, Dialysis, and Transplantation, 11(3), 521-525 (1996)
N J Bureau et al.
AJNR. American journal of neuroradiology, 35(8), 1467-1474 (2014-05-31)
Transforaminal corticosteroid injections can be performed in the management of cervical radiculopathy but carry the risk of catastrophic complications. This study compares the efficacy of transforaminal and facet corticosteroid injections at 4 weeks' follow-up. We randomly assigned 56 subjects to
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持